Protein provides new hope for a malaria vaccine

Protein provides new hope for a malaria vaccine

1 July 2016

Alan Cowman in lab
Professor Alan Cowman and his team have found a
way to stop the malaria parasite from invading healthy
blood cells.

Australian researchers have discovered a way to stop the malaria parasite invading healthy red blood cells, in a study giving fresh hope to the development of much-needed new anti-malarial treatment.

Research from the Walter and Eliza Hall Institute, led by Professor Alan Cowman, has shown that the malaria parasite cannot penetrate a human red blood cell when key proteins are deleted.

Approximately half of the world’s population is at risk of contracting malaria each year, with more than 200 million people infected. Malaria kills up to 450,000 people each year, predominantly children under the age of five.

Existing antimalarial drugs are becoming less effective as the parasite develops resistance to treatments, making the search for new targets critical.

Professor Cowman and his team have discovered that three proteins known as Rh5, Ripr and CyRPA together form a complex that plays a vital role in the ability of the Plasmodium falciparum parasite to invade healthy human blood cells.

In research that effectively removed or 'knocked out' the Ripr or CyRPA proteins, the malaria parasite was unable to invade the red blood cell, stopping malaria infection. Their findings have just been published in the journal Cell Host & Microbe.

“These findings hold great promise for understanding the function of these proteins and their development as vaccines” Professor Cowman said.

“Developing new vaccines for malaria is a global research priority,” he said.

The malaria parasite has developed resistance to most of the antimalarial drugs on the market and new treatments are urgently needed.

This work was supported by the National Health and Medical Research Council (NHMRC), the Victorian State Government Operational Infrastructure Support Program.


Further information:

P  +61 475 751 811



Super Content: 
Malaria parasite in the bloodstream

Visualisation of the parasite infection inside a pregnant female mosquito.

Close up view of pipetting in lab

We have developed the first malaria vaccine that can be tailored to match many different strains of malaria. 

Media in the lab

Find out about our latest research outcomes and scientific achievements.

Research team in a lab

Want to hear about our latest discoveries? Subscribe to our supporter newsletter, Illuminate